天然石用于管理肥胖疾病
Maria Maisto1, Adua Marzocchi1, Niloufar Keivani1
1Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano, 59, 80131 Naples, Italy.
International journal of molecular sciences
|November 14, 2023
概括
天然石灰石显示出对抗全球肥胖流行病的前景. 研究表明它们具有作为合成药物的安全替代品的潜力,这需要进一步的临床研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 代谢疾病 代谢疾病
背景情况:
- 全球肥胖流行病对公共健康构成重大风险,增加了2型糖尿病和心血管疾病等慢性疾病的发病率.
- 使用合成分子的传统肥胖治疗通常由于副作用和耐受性而存在局限性,这促使人们寻找天然替代品.
研究的目的:
- 审查天然石的抗肥胖潜力.
- 总结了体外和动物研究中的证据,这些证据是关于石的作用机制和治疗点.
主要方法:
- 对实验室和动物研究的综合文献综述,调查天然石英对抗肥胖作用.
- 在选定的研究中报告的分子标和作用机制的分析.
主要成果:
- 在体外研究中确定了特定的分子标和机制,通过这些标可以发挥各种抗肥胖作用.
- 动物研究表明,在管理与肥胖相关的参数方面,某些石具有有效性.
结论:
- 天然石灰石具有显著的抗肥胖潜力,为开发新型治疗策略提供了有前途的途径.
- 进一步的临床试验至关重要,以验证天然石在治疗和预防肥胖的有效性和安全性.
相关概念视频
Cholesterol: Significance and Regulation
559
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
559
Chronic Pancreatitis II: Collaborative Care
95
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
95
Glucagon-like Receptor Agonists
332
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
332
Direct-Acting Cholinergic Agonists: Therapeutic Uses
769
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
769
Cancer Prevention
6.2K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.2K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.2K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.2K


